Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
about
Non-Covalent Derivatives: Cocrystals and EutecticsImproved Stability and Smart-Material Functionality Realized in an Energetic CocrystalSmall-Scale Assays for Studying Dissolution of Pharmaceutical Cocrystals for Oral Administration.Acemetacin cocrystals and salts: structure solution from powder X-ray data and form selection of the piperazine saltCo-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients.Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins2-Amino-4-methyl-pyridinium 3-chloro-benzoate.2-Amino-5-bromo-pyridinium 2-hy-droxy-benzoate.Crystal structure of 5-amino-4H-1,2,4-triazol-1-ium pyrazine-2-carboxyl-ate: an unexpected salt arising from the deca-rboxylation of both precursorsDrugs as materials: valuing physical form in drug discovery.Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5Pharmaceutical Cocrystals and Their Physicochemical Properties.Benefits of cocrystallisation in pharmaceutical materials science: an update.Ionic liquids in drug delivery.The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics.Multicomponent Crystal Systems of Known Antimalarial Drug Molecules.Pharmaceutical cocrystals: along the path to improved medicines.Pharmaceutical cocrystals: walking the talk.Initial salt screening procedures for manufacturing ibuprofen.A zwitterionic 1D/2D polymer co-crystal and its polymorphic sub-components: a highly selective sensing platform for HIV ds-DNA sequences.Benzimidazolium 3,5-dicarb-oxy-benzoate trihydrate.2-[(2-Carboxyphenyl)disulfanyl]benzoate (1,5-dimethyl-3-oxo-2-phenyl-2,3-di-hydro-1H-pyrazol-4-yl)ammonium.Drug solubility: importance and enhancement techniques.Control of Assembly of Dihydropyridyl and Pyridyl Molecules via Directed Hydrogen BondingApplication of twin screw extrusion in the manufacture of cocrystals, part I: four case studies.Bis(4-carboxy-piperidinium) 5-nitro-isophthalateInvestigation of the Formation Process of Two Piracetam Cocrystals during Grinding.Crystal engineering to improve physicochemical properties of mefloquine hydrochloride.Andrographolide: solving chemical instability and poor solubility by means of cocrystals.Detection of cocrystal formation based on binary phase diagrams using thermal analysis.A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production - a case study with ursodeoxycholic acid.Multinuclear solid state NMR investigation of two polymorphic forms of ciprofloxacin-saccharinate.In vivo brain microdialysis as a formulation-screening tool for a poorly soluble centrally acting drug.Formation of isostructural solid solutions in 2,6-disubstituted N-phenylformamides and N-phenylthioamides.A tale of two polymorphic pharmaceuticals: pyrithyldione and propyphenazone and their 1937 co-crystal patent.Application of twin screw extrusion to the manufacture of cocrystals: scale-up of AMG 517-sorbic acid cocrystal production.Polymorphism and structural mechanism of the phase transformation of phenyl carbamate (PC).Dicarboxylic Acid Separation by Dynamic and Size-Matched Recognition in Solution and in the Solid State.
P2860
Q26796674-AF61AAFA-E6A5-4B61-AE67-68958B7E740CQ29042596-C43C67AA-3A49-4F19-A47D-6F2AAA55C4F1Q30375810-454D1915-4D20-4E90-BFFC-641E13EB04FAQ30839515-846A5642-84F6-427E-AB54-69FBC1721C1AQ33834542-DD2CF0FC-5553-4E73-9E09-72E942DC68F3Q34293676-06862ED4-F1E1-47E8-985E-AA4F1D0CA6A2Q34427824-71225E9E-74A9-4883-BEDA-F1A240BF7220Q34429364-E8B3B833-35D0-4458-99ED-22F4175971F1Q35900044-372F1D46-E825-4AA2-89A4-CB82434C0B40Q35936429-C6A1C280-B8B1-455F-927C-FC69EBB54912Q36442112-4C2B8BCB-DA07-415A-AAFB-08877898B47EQ37013110-E4A999C4-511A-4703-84E9-78CB3FC64411Q37510600-E01E358B-C36F-45AA-A517-AE0AE398185CQ37805586-D6BC315F-1020-4F5B-8E77-D32CBB1EF42EQ38116530-3E97B83C-08C4-4C7C-B74B-B9B6EB9B4347Q38162929-E393CAB3-BA51-46FB-8763-88FEB3864020Q38236638-F4AB4353-455F-4C1B-AE26-D273A8AEF2A0Q38586521-EBC65C71-208A-410F-9D60-1E726673AA36Q38632654-17BF830A-7F69-4015-BE2A-7CC89802CA9BQ38856202-9DE93CAE-57A1-4171-977F-9BC51A74B08CQ40028258-92BF13EB-3990-4C96-90F6-5EF6FE2E819CQ40906583-CEBB85C5-2C12-4246-918B-ECC6CC56F82FQ41349649-1EBFAEC4-A65D-45BB-8B5F-996B481CBBCEQ41765472-AD4C25EF-3E2B-4884-A6EE-95D2F3BC8A0BQ41885580-E156516C-5A4D-459B-A1E6-AAE8BCC45134Q41906571-50127D50-814E-4A56-8664-94BA223CC280Q42114331-AD56AA70-B6C0-4395-8996-C7CD52CBA3E1Q42126675-C624484E-D11C-4C6B-8F0E-703E07D213B7Q42830904-F5A10882-F7CE-4D79-BCBA-656B2621D662Q43119928-92BC3498-1F39-4A4E-BE25-E5EA2A5CB926Q43638088-5F8FF8A1-C30D-4026-8822-A7920E808001Q43787861-43C30800-F040-41E9-ACE9-C8203527A126Q44072586-A13CFE80-529C-4799-9EF4-81E1AE79E401Q44607428-7B6A3666-7CF6-4533-92DA-F7176AF643F8Q46646546-CB53082D-E2F8-453D-83C6-8AEE4C742A05Q46685426-D38E1B08-171F-4359-9D24-43DC44E9CC0FQ46768022-4B278D32-3FF3-422F-8520-F5749D90F300Q46955396-C0B3284A-6AC0-4D1B-A470-6B249BA7EFE0Q46959715-D90EBC1B-F96E-4B2D-8073-C9C2CC69D3F4Q47174280-CA4765F7-C790-4D9E-A9A2-AE5C37EEBE3F
P2860
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@en
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@nl
type
label
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@en
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@nl
prefLabel
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@en
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@nl
P2093
P356
P1476
Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
@en
P2093
Brian Moulton
Héctor R Guzmán
J Michael MacPhee
Julius F Remenar
Matthew L Peterson
Orn Almarsson
Sherry L Morissette
P304
P356
10.1021/JA035776P
P407
P577
2003-07-01T00:00:00Z